RG-6436

N/A

Report date: 2024/06/04 16:04:03
NME

Base Information

Drug NameRG-6436
Drug Alias NameRG-6436RG6436
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeptin receptor modulators
TargetsLeptin receptor
Therapy Area/IndicationsUrinary Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesGenentech IncEnterprise Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGenentech IncEnterprise Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsUrinary Tract Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A